The present invention relates to a novel sulfonic acid derivative of hydroxamic
acid or a pharmacologically acceptable salt thereof. More particularly, the present
invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically
acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides
(LPS). In addition, the present invention relates to a novel intermediate compound
useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.